Follow the entities shaping the evidence.

…making.Abstract SC35 Table 1Characteristics of 1004 people with HIV (PWH) according to treatment status at last visitAbstract SC35 …

…y of the FDA-approved 4CMenB vaccine in preventing experimental N. gonorrhoeae infection. Our research team is currently the only in the world…

…fore their pregnancy (OR: 0.24, 95% CI 0.18 to 0.32).Conclusion Option B+ improved postpartum retention among PWLWH newly eligible for li…

… (EVT) is superior to medical management (MM) for patients with acute large infarcts. However, evidence remains limited for patients with large infa…

…rkinson’s disease (PD), often progressing to PD dementia (PDD). Deep brain stimulation (DBS) is an established treatment for PD motor symptoms, but it…

…ain—ranibizumab, aflibercept (2 mg and 8 mg), brolucizumab, and faricimab—each differing in dosing interval, mechanism, and cost. Compara…

…and motor deficits and often pathogenic variants in SCN1A gene. Lennox–Gastaut syndrome typically presents with seizure between 1–7 years and has genet…

…effect of the medications.Conclusion and Relevance In severe T2 asthma, eosinophilic phenotype, nasal polyposis, and frequent exacerba…

…% CI 23.7 – 50.3)) SELADELPAR (ARR = 40.9 (95% CI 28.1 – 53.8)) ELAFIBRANOR (ARR = 47.2 (95% CI 36.4 – 57.9)) ARR = 10.2 (-6.9 ; 27,3) p = …

…iaodong S, Berliner AJ, et al. Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non…

…ITP) who are refractory to conventional treatments. Among them, eltrombopag and avatrombopag have demonstrated significant efficacy in incr…

…nclusion and Relevance Immunotherapy has significantly improved melanoma prognosis, albeit at high drug-related costs. In the adjuvant s…